title: Impact of race on the severity of acute episodes of asthma and adrenergic responsiveness.
abstract: BACKGROUND
  African Americans acutely ill with asthma come to emergency departments more frequently and are admitted to hospital more often than whites but the reasons are unclear.
  
  
  OBJECTIVE
  To determine whether such phenomena represent racial differences in attack severity or limited effectiveness of beta(2)-agonist therapy.
  
  
  RESULTS
  We contrasted clinical features, airflow limitation, and albuterol responsiveness in adults acutely ill with asthma, 155 of whom where African American and 140 white, as they presented to eight emergency departments. Assessments were standardized across institutions using a care path, and admission and discharge decisions were made according to predetermined criteria. The degree of obstruction was measured by peak expiratory flow rates. The clinical features of both groups were similar. The African Americans, however, had lower flow rates (p = 0.002), and more of them experienced severe or potentially life threatening episodes (p < 0.001). Albuterol was equally efficacious in both populations and there were no differences in the post-treatment flow rates achieved irrespective of the initial attack intensity. There were no racial differences in admission/discharge ratios.
  
  
  CONCLUSIONS
  Our data indicate that African Americans with asthma tend to present with somewhat more intense attacks than whites, but they respond equally well to routine treatment. Similarly, there were no racial disparities in hospitalizations when standard criteria are employed.
authors.affiliation: Division of Pulmonary, Critical Care, and Sleep Medicine, Cleveland, OH 44109, USA.
authors.forename: Amr
authors.initials: A
authors.lastname: El-Ekiaby
authors.forename: Lori
authors.initials: L
authors.lastname: Brianas
authors.forename: Mary E
authors.initials: ME
authors.lastname: Skowronski
authors.forename: Albert J
authors.initials: AJ
authors.lastname: Coreno
authors.forename: Gayle
authors.initials: G
authors.lastname: Galan
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Kaeberlein
authors.forename: Roy E
authors.initials: RE
authors.lastname: Seitz
authors.forename: Karen D
authors.initials: KD
authors.lastname: Villaba
authors.forename: Howard
authors.initials: H
authors.lastname: Dickey-White
authors.forename: E R
authors.initials: ER
authors.lastname: McFadden
mesh_terms: D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D001741:Black or African American / Q000706:statistics & numerical data*; D000420:Albuterol / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000208:ethnology* / Q000503:physiopathology; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D008297:Male; D010366:Peak Expiratory Flow Rate / Q000502:physiology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D044465:White People / Q000706:statistics & numerical data*
chemical_list: D000318:Adrenergic beta-Agonists; D000420:Albuterol